Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Interventions

Cyclophosphamide 1492 Cisplatin 1415 Paclitaxel 1319 Radiotherapy 1261 Carboplatin 1250 Gemcitabine 1215 Docetaxel 1111 Bevacizumab 1031 Fluorouracil 895 Doxorubicin 792 Dexamethasone 748 Rituximab 720 Capecitabine 717 Oxaliplatin 701 pembrolizumab 680 Etoposide 678 Irinotecan 636 Filgrastim 621 Cytarabine 586 Leucovorin 579 Nivolumab 560 Vincristine 515 Prednisone 475 Cetuximab 465 Bortezomib 459 Erlotinib Hydrochloride 456 Trastuzumab 447 Methotrexate 438 Lenalidomide 428 Pemetrexed 420

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Interventional × recombinant FVIIa × Clear all

NCT02622321 2021-06-24

HAVEN 1

Hoffmann-La Roche

Phase 3 Completed

113 enrolled 45 charts 1 FDA

Classical hematology

Hemophilia A

Data powered by HemOnc (CC BY 4.0) Colophon ⚡